Edward Shen

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC.

Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC.

Journal: Hepatology (Baltimore, Md.)
Published: September 30, 2023

A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.

A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.

Journal: iScience
Published: November 28, 2022

Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma.

Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma.

Journal: Frontiers in immunology
Published: May 24, 2022

MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma.

MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma.

Journal: iScience
Published: February 25, 2022

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model.

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model.

Journal: EBioMedicine
Published: September 28, 2021

Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality.

Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality.

Journal: Gut pathogens
Published: July 23, 2021

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 12, 2021

tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner.

tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 05, 2021

M6A "Writer" Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer.

M6A "Writer" Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer.

Journal: Frontiers in oncology
Published: January 25, 2021

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.

Journal: Aging
Published: July 27, 2020

A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy.

A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy.

Journal: Aging
Published: June 16, 2020

MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her-2/PI3K/AKT Signaling.

MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her-2/PI3K/AKT Signaling.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 09, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026